File(s) under permanent embargo
Stem cells and regenerative medicine: From research to clinical applications
journal contribution
posted on 2023-05-17, 18:43 authored by Donald ChalmersDonald Chalmers, Rathjen, P, Rathjen, J, Dianne NicolDianne NicolStem cell science has attracted widespread international interest in recent years. Stem cells are valuable tools for basic science. There are considerable hopes that stem cell technology may lead to treatments for degenerative diseases such as Parkinson's disease, and for ischemic events, such as stroke and heart attack. Stem cells may become sources for replacement and transplantation tissue for nerve, muscle, blood, liver, pancreatic and heart diseases. The science has accelerated over the last decade, especially since the discovery of pluripotent embryonic stem (ES) cells in humans in 1998. The term "regenerative medicine" is increasingly used as stem cell research moves towards clinical applications, such as trials to address macular degenerative disorders. This article examines the current state of the science of stem cell technology, the regulatory frameworks established for the derivation of stem cells, particularly from human embryos, which has attracted the greatest ethical and legal controversy, and the translation of stem cell research to clinical applications.
History
Publication title
Journal of Law and MedicineVolume
20Issue
4Pagination
831-844ISSN
1320-159XDepartment/School
Faculty of LawPublisher
Thomson ReutersPlace of publication
PyrmontRights statement
Copyright 2013 Thomson ReutersRepository Status
- Restricted